1. Das, Debajyoti, Sharma, Mridul, Gahlot, Deepanshi, Martinez-Lopez, Nuria, Singh, Rajat. 2024. VPS4A is the selective receptor for lipophagy in mice and humans. In Molecular cell, 84, 4436-4453.e8. doi:10.1016/j.molcel.2024.10.022. https://pubmed.ncbi.nlm.nih.gov/39520981/
2. Dvilansky, Inbar, Altaras, Yarin, Kamenetsky, Nikita, Nachmias, Dikla, Elia, Natalie. 2024. The human AAA-ATPase VPS4A isoform and its co-factor VTA1 have a unique function in regulating mammalian cytokinesis abscission. In PLoS biology, 22, e3002327. doi:10.1371/journal.pbio.3002327. https://pubmed.ncbi.nlm.nih.gov/38687820/
3. Hamdan, Fadi F, Srour, Myriam, Capo-Chichi, Jose-Mario, Rouleau, Guy A, Michaud, Jacques L. 2014. De novo mutations in moderate or severe intellectual disability. In PLoS genetics, 10, e1004772. doi:10.1371/journal.pgen.1004772. https://pubmed.ncbi.nlm.nih.gov/25356899/
4. Han, Qingfang, Lv, Lihong, Wei, Jinxing, Liu, Peiqing, Min, Jun. 2019. Vps4A mediates the localization and exosome release of β-catenin to inhibit epithelial-mesenchymal transition in hepatocellular carcinoma. In Cancer letters, 457, 47-59. doi:10.1016/j.canlet.2019.04.035. https://pubmed.ncbi.nlm.nih.gov/31059752/
5. Rodger, Catherine, Flex, Elisabetta, Allison, Rachel J, Tartaglia, Marco, Reid, Evan. 2020. De Novo VPS4A Mutations Cause Multisystem Disease with Abnormal Neurodevelopment. In American journal of human genetics, 107, 1129-1148. doi:10.1016/j.ajhg.2020.10.012. https://pubmed.ncbi.nlm.nih.gov/33186545/
智鼠故事 
